Trials / Active Not Recruiting
Active Not RecruitingNCT07161635
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.
Detailed description
Subjects will attend 9 scheduled study visits for a total individual duration of participation of approximately 7 months. Both eyes will undergo cataract surgery. The second eye surgery will occur within 7 to 14 days of the first.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Clareon PanOptix Pro/Pro Toric Trifocal IOL | Intraocular lens (IOL) placed into the lens capsule of the eye during cataract surgery. IOLs are implantable medical devices intended for long-term use over the lifetime of the pseudophakic subject. |
| PROCEDURE | Phacoemulsification | Cataract surgery technique that uses ultrasound to break up and remove the clouded lens, allowing for IOL implantation. |
Timeline
- Start date
- 2025-10-14
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2025-09-08
- Last updated
- 2026-04-15
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07161635. Inclusion in this directory is not an endorsement.